AxoGen, Inc.
AxoGen, Inc. (AXGN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AXGN · as of Mar 31, 2025
Ownership Breakdown
185
Institutional Holders
▲ 10 vs Q4
$720.08M
Total Inst. Value
▲ $129.30M vs Q4
53.18M
Shares Outstanding
freeFloat 97.85%
38.93M
13F Shares Held
▲ 3.08M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AXGN largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FIRST LIGHT ASSET MANAGEMENT, LLC electromedical & electrotherapeutic apparatus | 4.47M | 9.90% | 9.90% | $82.77B | May 15, 2025 | ▼ 32.6K |
BLACKROCK, INC. electromedical & electrotherapeutic apparatus | 3.55M | 7.86% | 7.86% | $65.69B | May 2, 2025 | ▲ 150.1K |
MORGAN STANLEY electromedical & electrotherapeutic apparatus | 2.60M | 5.75% | 5.75% | $48.12B | May 15, 2025 | ▲ 170.8K |
VANGUARD GROUP INC electromedical & electrotherapeutic apparatus | 2.54M | 5.62% | 5.62% | $46.96B | May 9, 2025 | ▲ 112.7K |
ARROWMARK COLORADO HOLDINGS LLC electromedical & electrotherapeutic apparatus | 1.59M | 3.52% | 3.52% | $29.44B | May 15, 2025 | ▼ 657.7K |
SOLEUS CAPITAL MANAGEMENT, L.P. electromedical & electrotherapeutic apparatus | 1.45M | 3.20% | 3.20% | $26.75B | May 15, 2025 | ▼ 1.51M |
DRIEHAUS CAPITAL MANAGEMENT LLC electromedical & electrotherapeutic apparatus | 1.17M | 2.59% | 2.59% | $21.68B | May 15, 2025 | ▲ 217.6K |
GEODE CAPITAL MANAGEMENT, LLC electromedical & electrotherapeutic apparatus | 1.03M | 2.27% | 2.27% | $19.00B | May 13, 2025 | ▲ 19.9K |
STATE STREET CORP electromedical & electrotherapeutic apparatus | 1.01M | 2.24% | 2.24% | $18.77B | May 15, 2025 | ▲ 49.1K |
ASSENAGON ASSET MANAGEMENT S.A. electromedical & electrotherapeutic apparatus | 1.00M | 2.21% | 2.21% | $18.52B | Apr 15, 2025 | ▲ 174.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
25
Increased
+3.95M shares4
New Positions
first time holders20
Decreased
−2.99M shares0
Sold Out
fully exitedNet shares change (top 50)
+965.1K
+3.95M / −2.99M
Net new holders
+9
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AXGN insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
4
Buy transactions
10
Sell transactions
0.40
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Wendell Amy McBride director | May 8, 2026 | Sale | 1,647 | $42.60 | $70.2K | 93.8K | Form 4 ↗ |
JOHNSON JOHN director | May 7, 2026 | Sale | 11,050 | $43.26 | $478.0K | 0 | Form 4 ↗ |
Weiler Kathy Johnson director | May 7, 2026 | Sale | 16,344 | $44.09 | $720.6K | 0 | Form 4 ↗ |
Kemp Jens Chief Marketing Officer | May 7, 2026 | Sale | 4,000 | $43.44 | $173.8K | 72.5K | Form 4 ↗ |
Hartley Lindsey Marie CFO | May 7, 2026 | Sale | 573 | $43.67 | $25.0K | 65.1K | Form 4 ↗ |
Hartley Lindsey Marie CFO | May 7, 2026 | Sale | 478 | $43.67 | $20.9K | 62.8K | Form 4 ↗ |
Quackenbush Doris Sales VP | May 7, 2026 | Sale | 3,878 | $43.51 | $168.7K | 92.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
AxoGen, Inc. (AXGN) is primarily owned by institutional investors, who hold approximately 73.2% of total shares outstanding. Company insiders own approximately 2.15%, while retail and public investors account for the remaining 24.64%.
The largest institutional shareholder of AxoGen, Inc. is FIRST LIGHT ASSET MANAGEMENT, LLC, holding approximately 4.47 million shares — equal to 9.90% of outstanding shares — as of March 31, 2025.
A total of 185 institutional investors currently hold AXGN stock, with a combined institutional value of approximately $720,075,324 as of the most recent 13F filing period.
Frequently asked questions
AXGN ownershipAxoGen, Inc. (AXGN) is primarily owned by institutional investors, who hold approximately 73.2% of shares. The largest shareholder is FIRST LIGHT ASSET MANAGEMENT, LLC with a 9.90% stake. Company insiders hold 2.15%. Data sourced from SEC Form 13F as of March 31, 2025.